Pharma news
Pharma
In a victory for GlaxoSmithKline, the US Court of Appeals for the Federal Circuit has revived a 2017 jury verdict ordering Teva to pay $235 million over the drug Coreg. 6 October 2020
Americas
A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission. 2 October 2020
Americas
Massachusetts-based Collegium Pharmaceutical has reached a settlement agreement with Teva, resolving its patent litigation over pain medication. 30 September 2020
Americas
The US Court of Appeals for the Federal Circuit has sided with EMD Serono and Pfizer over the invalidation of a multiple sclerosis drug patent, in a defeat for biotech company Biogen. 29 September 2020
Americas
MSD subsidiary Idenix has urged the US Supreme Court to review the overturning of a record $2.5 billion verdict against Gilead Sciences. 28 September 2020
Americas
The US Patent Trial and Appeal Board has invalidated parts of an AbbVie patent covering blood disease drug Imbruvica. 25 September 2020
Americas
Danish biotech Genmab has commenced binding arbitration of two matters with Janssen Biotech, a Johnson & Johnson company, over royalty payments for a cancer drug. 24 September 2020
Americas
Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement. 23 September 2020
Pharma
The European Patent Office has invalidated and revoked a patent related to Teva’s
multiple sclerosis drug Copaxone, in a win for Mylan. 17 September 2020
Americas
Merck & Co is set to make a $1 billion investment in biotech company Seattle Genetics, as the companies collaborate to develop and sell Seattle Genetics’ cancer therapy, ladiratuzumab vedotin. 16 September 2020